Clioquinol's Return: Cautions from Japan
- 22 June 2001
- journal article
- letter
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 292 (5525) , 2251-2252
- https://doi.org/10.1126/science.292.5525.2251
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MicePublished by Elsevier ,2001
- Subacute myelo‐optico‐neuropathy: Clioquinol intoxication in humans and animalsNeuropathology, 2000
- Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinolJournal of the Neurological Sciences, 2000
- Clioquinol-Zinc Chelate: A Candidate Causative Agent of Subacute Myelo-Optic NeuropathyMolecular Medicine, 1998
- Neurotoxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- Subacute myelo-optic neuropathy and clioquinol. An epidemiological case-history for diagnosis.Journal of Epidemiology and Community Health, 1975
- AETIOLOGICAL AND CLINICAL STUDY ON SUBACUTE MYELO-OPTICO-NEUROPATHY (SMON)Nihon Naika Gakkai Zasshi, 1974
- Identification of green pigment and analysis of clioquinol in specimens from patients with subacute myelo-optico-neuropathyClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- RELATION BETWEEN SUBACUTE MYELO-OPTIC NEUROPATHY (S.M.O.N.) AND CLIOQUINOL: NATIONWIDE SURVEYThe Lancet, 1973